← Eichor
Condition: Peptides Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Peptides

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides
NA · 1 location(s) · Chung Shan Medical University · NCT07504029Imaging CRF X NOP Interactions in Alcohol Use Disorder
EARLY_Phase 1 · 1 location(s) · Rajesh Narendran · NCT07612631Food and Fitness With Medicine (FFWM)
NA · 4 location(s) · Ohio State University · NCT07027995Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 · 8 location(s) · Orano Med Theranostics, SAS · NCT05283330Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabete
Phase 3 · 116 location(s) · Kailera · NCT07284901LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
Phase 2 · 9 location(s) · Arch Biopartners Inc. · NCT05879432A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
Phase 1/Phase 2 · 12 location(s) · Enterome · NCT04669171Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides
EARLY_Phase 1 · 1 location(s) · Azienda Ospedaliero-Universitaria Consorziale Policlinico di · NCT06138236Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
Phase 2 · 2 location(s) · Carmen Clapp · NCT03161652Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
EARLY_Phase 1 · 1 location(s) · Oslo University Hospital · NCT07341360GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
NA · 1 location(s) · University of Alabama at Birmingham · NCT05216042Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Meta
Phase 2 · 4 location(s) · University Hospital, Bordeaux · NCT04837885Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treat
Phase 2 · 2 location(s) · The First Affiliated Hospital of Nanchang University · NCT06751901Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · 12 location(s) · PYC Therapeutics · NCT06714006Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion
Phase 1 · 2 location(s) · University Hospital Tuebingen · NCT06789198Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NA · 2 location(s) · The First Affiliated Hospital of Nanchang University · NCT06751914ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Phase 1 · 1 location(s) · Katy Peters, MD, PhD · NCT05609994RADA16 for Adult Tonsillectomy
Phase 3 · 2 location(s) · Rutgers, The State University of New Jersey · NCT07060495Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Phase 2 · 2 location(s) · Anders Fink-Jensen, MD, DMSci · NCT06939088Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NA · 2 location(s) · The First Affiliated Hospital of Nanchang University · NCT06751966A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treat
Phase 2 · 36 location(s) · BioMarin Pharmaceutical · NCT06668805Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
Phase 4 · 1 location(s) · Nordsjaellands Hospital · NCT07136714EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.
Phase N/A · 1 location(s) · IRCCS San Raffaele Roma · NCT05570149Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
Phase 1 · 1 location(s) · Chinese PLA General Hospital · NCT05631886Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
Phase N/A · 2 location(s) · Methodist Health System · NCT0409003468Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06500065Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)
Phase 2 · 2 location(s) · The University of Hong Kong-Shenzhen Hospital · NCT06314087Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subje
Phase 3 · 179 location(s) · Greenwich LifeSciences, Inc. · NCT05232916Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429Effect of C-peptide on Hypoglycemic Counterregulation
EARLY_Phase 1 · 1 location(s) · University of Cincinnati · NCT06470295
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.